Purpose-built for physicians GLP-1RAs improve ALT in pediatric MASLD, could be powerful option for some patients Key takeaways: Treatment with GLP-1RAs resulted in significant mean reductions in ALT by 23.4 U/L at 6 months and by 18.2 U/L overall
Foods high in protein, fiber, and healthy fats can naturally support GLP-1 but putting that into practice consistently is where most people struggle
GLP-1 medications have been all over the news lately
An alternative starting protocol uses 1mg for the first four weeks before moving to 2mg, then following the standard escalation from there
For many patients, these injectables deliver the most consistent, clinically proven reductions in body weight
The medication lowers your blood sugar levels, which contributes to weight loss